Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 May, 2026Executive summary
Net sales for Q1 2026 reached €477,678, up from €469,354 year-over-year.
Profit after tax for the period was €70,031, more than double the €34,837 from Q1 2025.
Earnings per share increased to €0.166 from €0.082 year-over-year.
Financial highlights
Operating income before tax was €70,061, compared to €34,880 in Q1 2025.
Other operating income rose to €24,941 from €18,911 year-over-year.
Cash and equivalents at period end were €136,955, up from €53,500 at Q1 2025 end.
Shareholders' equity increased to €1,990,745 from €1,920,714 at year-end 2025.
Outlook and guidance
Financial information prepared using consistent principles as prior annual reports.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- 2025 net turnover rose 17.3% to €1.94M, but profit fell to €29.1K; dividend payout proposed.SCM1R
Q4 202523 Mar 2026 - Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.SCM1R
Q3 202520 Nov 2025 - Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.SCM1R
Q2 202521 Aug 2025 - Net sales rose 6% but net profit and EPS declined for the nine months of 2024.SCM1R
Q3 202413 Jun 2025 - Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.SCM1R
Q2 202413 Jun 2025 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 20249 Jun 2025 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 20256 Jun 2025